Accès ouvert

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial—an update to the published protocol

Article scientifique 2024 Anglais

Résumé

This article reports an update to the protocol of the IMASOY trial, which was prospectively registered on clinicaltrials.gov (NCT04110340) in October 2019.

Citer ce document

Randremanana, R., Raberahona, M., Randria, M., Bourner, J., Zadonirina, G., Razananaivo, H., Mayouya-Gamana, T., Mangahasimbola, R., Pesonel, E., Gillesen, A., Rajerison, M., Andrianaivoarimanana, V., Edwards, T., Horby, P., Olliaro, P. (2024). An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial—an update to the published protocol. https://doi.org/10.1186/s13063-024-08302-7

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Auteur(s)

Rindra Vatosoa Randremanana Mihaja Raberahona Mamy Jean de Dieu Randria Josephine Bourner Gabriella Zadonirina Hanitra Razananaivo Théodora Mayouya-Gamana Reziky Tiandraza Mangahasimbola Elise Pesonel Annelies Gillesen Minoarisoa Rajerison Voahangy Andrianaivoarimanana Tansy Edwards Peter Horby Piero Olliaro

Statistiques

Consultations : 1

Téléchargements : 0